Largest health care biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 health care biotech companies ranked by total assets, at SGD 117B, ahead of Gilead Sciences (SGD 76.2B) and Biogen (SGD 38B). Figures as of 19 Nov 2026, 23:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenSGD 117B
- Median
- SGD 3.3B
- Combined market value
- SGD 1.07T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | SGD 117B | SGD 306.6B | SGD 566.89 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | SGD 76.2B | SGD 266.8B | SGD 215.13 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | SGD 38B | SGD 47.2B | SGD 319.25 | 1.70% down | 49% up | ||
| 4 | BioNTechBNTX · Health Care | SGD 31.5B | SGD 26.1B | SGD 105.13 | 2.26% down | 14% down | ||
| 5 | ModernaMRNA · Health Care | SGD 15.9B | SGD 104.2B | SGD 257.50 | 1.29% up | 780% up | ||
| 6 | argenxARGX · Health Care | SGD 11.2B | SGD 76.5B | SGD 1,216.96 | 0.08% up | 2% up | ||
| 7 | QiagenQGEN · Health Care | SGD 8.1B | SGD 13.2B | SGD 64.11 | 0.14% up | 9% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | SGD 6B | SGD 20.5B | SGD 202.29 | 3.85% down | 17% up | ||
| 9 | VaxcytePCVX · Health Care | SGD 3.9B | SGD 11.9B | SGD 75.39 | 0.27% down | 23% up | ||
| 10 | RepligenRGEN · Health Care | SGD 3.8B | SGD 14.1B | SGD 219.99 | 1.38% down | 12% up | ||
| 11 | ExelixisEXEL · Health Care | SGD 3.7B | SGD 20.8B | SGD 85.04 | 3.60% down | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | SGD 3.3B | SGD 14.8B | SGD 93.92 | 0.07% down | 24% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | SGD 3.3B | SGD 13.7B | SGD 120.19 | 2.88% down | 39% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | SGD 3B | SGD 44.5B | SGD 205.96 | 0.24% down | 129% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | SGD 2.9B | SGD 4.9B | SGD 50.29 | 3.14% down | 18% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | SGD 2.3B | SGD 13.2B | SGD 154.23 | 1.44% down | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | SGD 1.7B | SGD 12.1B | SGD 407.99 | 0.15% up | 54% up | ||
| 18 | ImmunovantIMVT · Health Care | SGD 1.2B | SGD 8.7B | SGD 42.01 | 1.96% down | 46% up | ||
| 19 | CG OncologyCGON · Health Care | SGD 1B | SGD 9.5B | SGD 105.80 | 2.38% up | 97% up | ||
| 20 | Twist BioscienceTWST · Health Care | SGD 829.2M | SGD 9.8B | SGD 144.20 | 4.07% down | 346% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | SGD 662.4M | SGD 5.9B | SGD 36.24 | 1.44% down | 74% up | ||
| 22 | ImmunityBioIBRX · Health Care | SGD 648.4M | SGD 9B | SGD 8.49 | 1.94% down | 232% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | SGD 522.3M | SGD 7.9B | SGD 65.07 | 4.94% up | 26% up | ||
| 24 | Kodiak SciencesKOD · Health Care | SGD 454.1M | SGD 8.3B | SGD 126.47 | 0.09% up | 399% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2918 SGD).
Questions and answers
Which health care biotech companies rank first by total assets?
Amgen (SGD 117B), Gilead Sciences (SGD 76.2B) and Biogen (SGD 38B) are the top three of the 24 health care biotech companies ranked by total assets as of 19 Nov 2026, 23:27 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by total assets.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by total assets have a combined market value of SGD 1.07T as of 19 Nov 2026, 23:27 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.